Insights

The Ultra Expensive Drugs. Who’s paying? With the entry of Zolgensma into the market in 2019, the prescription drug market changed almost instantly. T...

Combined companies create a leading pharmacy benefit optimizer to help benefits consultants and plan sponsors tackle tough challenges including cost, ...

On Friday, August 20, 2021, the Departments of Labor, Health and Human Services (HHS) and the Treasury (collectively, the Departments) released update...

Estimate impact of high-risk COVID population Background As expected, on August 12, the U.S. Food and Drug Administration (FDA) authorized a booster d...

Baltimore-based pharmacy benefits consulting firm ranks among the top 5000 fastest-growing companies in the United States.

Digital Therapeutics (DTx) is somewhat of a new term in the healthcare realm, but this is one trend in the industry that is likely to stick around.

Combined company will enable the organizations to further simplify increasingly complex and inefficient models for managing pharmacy.

Confidio’s Net Economic Value model provides a navigation system for selecting your PBM

As of mid June, at least 173.8 million people have received one or both doses of a coronavirus vaccine in the U.S. This includes more than 143.9 milli...

*Co-Authored By: Brian Maas, RPh Clinical Consultant

Investing in top talent to develop sustainable and trusted solutions

At Confidio, we are continuing to monitor the important changes in regulations regarding price transparency. The Federal Government will issue additio...